AI assistant
Sending…
AMGEN INC — Director's Dealing 2012
Aug 27, 2012
29819_dirs_2012-08-27_be604b50-268e-4221-af45-f98515e7fc04.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-08-24
Reporting Person: PELHAM JUDITH C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-24 | Common Stock | M | 5000 | $74.89 | Acquired | 26304 | Direct |
| 2012-08-24 | Common Stock | S | 5000 | $84.3665 | Disposed | 21304 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-24 | Nqso (Right to Buy) | $74.89 | M | 5000 | Disposed | 2013-03-15 | Common Stock (5000) | Direct |
Footnotes
F1: The price reported is an average price. The prices ranged from $84.3501 to $84.3801 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
More from AMGEN INC
Audit Report / Information
2026
Jun 11
Audit Report / Information
2026
Jun 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Board/Management Information
2026
May 19
Interim / Quarterly Report
2026
May 1
Earnings Release
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Board/Management Information
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 15